Product Images Sumatriptan Succinate

This is a description of Sumatriptan Succinate Tablets, a medication used to treat migraines, with a dosage of 25mg of Sumatriptan in each tablet. The tablets are manufactured by Sun Pharmaceuticals Industries, Inc, under the generic name Imitrex. The package includes information on the dosage and warnings to take the tablets whole and not to store them in any other package. Additionally, the package warns that the medication is only to be used by the patient to whom it was prescribed. Details related to the product's production, lot number, and expiration date are also included.*

Figure 1 displays the estimated probability of initial headache response within 4 hours of treatment with oral sumatriptan. The graph shows the probability of response over time for different doses; 25mg, 50mg, and 100mg. The averages are based on pooled data from 3 clinical controlled trials evaluating the efficacy of the treatment. The x-axis represents the time in minutes from the initial dose, while the y-axis represents the estimated probability of response. The figure demonstrates that higher doses of sumatriptan have a greater chance of achieving initial headache response.*

The text describes a figure showing the estimated probability of patients taking a second dose of Sumatriptan Succinate or other medication to treat migraine over 24 hours following the initial dose of study treatment in Pooled Trials 1, 2, and 3. A Kaplan-Meier plot is used based on data obtained in three clinical controlled trials. Patients who did not use additional treatment during the 24 hour period and those who had no response to the initial dose were included in the plot, and remedication was not allowed within 2 hours postdose.*